Table 3 MMSE and FIM scores at baseline and at follow up for patients with or without apathy at both assessments, and for patients having no apathy at baseline but apathy at follow up.
| No apathy at both assessments | Apathy at both assessments | No apathy at baseline, apathy at follow up | ||||
|---|---|---|---|---|---|---|
| MMSE | ||||||
| No. of patients | 138 | 60 | 41 | |||
| Interval (months) | 18.1 (8.9) | 17.2 (10.0) | 20.5 (8.3) | |||
| Baseline score | 23.6 (5.4) | 19.8 (6.2) | 20.5 (5.0) | |||
| Follow up score | 23.2 (6.3) | 17.8 (7.2) | 16.8 (6.8) | |||
| FIM | ||||||
| No. of patients | 126 | 56 | 37 | |||
| Interval (months) | 18.0 (8.7) | 18.2 (9.6) | 20.1 (10.7) | |||
| Baseline score | 67.1 (6.4) | 61.3 (6.6) | 64.9 (12.2) | |||
| Follow up score | 65.2 (7.1) | 56.8 (16.8) | 56.2 (14.0) |
Data are mean (SD). MMSE: group effect (F(2,236) = 8.70, p = 0.0002), time effect (F(1,236) = 33.8, p<0.0001), group by time interaction (F(2,236) = 7.39, p = 0.0007). FIM: group effect (F(2,216) = 13.8, p<0.0001), time effect (F(1,216) = 31.0, p<0.0001), group by time interaction (F(2,216) = 5.17, p = 0.006).